Qsemble Capital Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-89,446
Closed -$6.33M 504
2026
Q1
$6.33M Buy
+89,446
New +$6.7M 0.48% 67
2025
Q4
Sell
-33,274
Closed -$2.74M 570
2025
Q3
$2.74M Sell
33,274
-57,620
-63% -$4.53M 0.27% 119
2025
Q2
$7.31M Sell
90,894
-5,347
-6% -$413K 0.7% 41
2025
Q1
$7.73M Buy
+96,241
New +$8M 0.82% 21
2023
Q4
Sell
-66,300
Closed -$4.17M 432
2023
Q3
$4.17M Buy
+66,300
New +$4.13M 0.78% 34
2023
Q1
Sell
-22,600
Closed -$1.64M 299
2022
Q4
$1.64M Buy
+22,600
New +$1.62M 1.14% 14

Other funds holding MET

Qsemble Capital Management's MET Position: Q2 2026 in Review

Qsemble Capital Management sold out of MetLife (MET) in Q2 2026, closing a stake of 89,446 shares — an estimated $6.33M sold.

Qsemble Capital Management first reported a position in MET in Q4 2022 and held it in 6 quarters. The position peaked at $7.73M in Q1 2025. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Qsemble Capital Management reported no remaining MetLife position as of Q2 2026 after selling out during the quarter.
  • Qsemble Capital Management sold 89,446 MetLife shares in Q2 2026, an estimated $6.33M.
  • Qsemble Capital Management first reported a position in MetLife in Q4 2022 and held it in 6 quarters.
  • Qsemble Capital Management's MetLife position peaked at $7.73M in Q1 2025.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.